Previous Article | Next Article 
Journal of Virology, October 2000, p. 9655-9667, Vol. 74, No. 20
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Internalization of Adenovirus by Alveolar
Macrophages Initiates Early Proinflammatory Signaling during Acute
Respiratory Tract Infection
Zsuzsanna
Zsengellér,1,
Kazuhisa
Otake,1,
Shaikh-Abu
Hossain,1
Pierre-Yves
Berclaz,2 and
Bruce C.
Trapnell1,*
Division of Pulmonary
Biology1 and Division of Pulmonary
Medicine,2 Children's Hospital Medical
Center, Cincinnati, Ohio 45229
Received 30 March 2000/Accepted 13 July 2000
 |
ABSTRACT |
Adenovirus is a common respiratory pathogen which causes a broad
range of distinct clinical syndromes and has recently received attention for its potential for in vivo gene delivery. Although adenovirus respiratory tract infection (ARTI) results in
dose-dependent, local inflammation, the pathogenesis of this remains
unclear. We hypothesized that alveolar macrophages (AM
) rapidly
internalize adenovirus following in vivo pulmonary administration and
then initiate inflammatory signaling within the lung. To evaluate the role of AM
in the induction of lung inflammation during ARTI in
vivo, we directly assessed adenovirus uptake by murine AM
and
correlated uptake with the initiation of proinflammatory gene expression. Stimulation of cytokine (tumor necrosis factor alpha [TNF-
], interleukin-6 [IL-6], macrophage
inflammatory protein-2 [MIP-2], and MIP-1
) expression in the lung
was evaluated at the level of mRNA (by reverse transcription-PCR
[RT-PCR]) and protein (by enzyme-linked immunosorbent assay) and by
identification of cells expressing TNF-
and IL-6 mRNA in lung
tissues (by in situ hybridization) and isolated lung lavage cells (by
RT-PCR). Adenovirus, labeled with the fluorescent dye (Cy3), was
rapidly and widely distributed on epithelial surfaces of airways and
alveoli and was very rapidly (~1 min) localized within AM
. At 30 min after infection AM
but not airway epithelial or vascular
endothelial cells expressed mRNA for TNF-
and IL-6, thus identifying
AM
as the cell source of initial cytokine signaling. IL-6, TNF-
, MIP-2, and MIP-1
levels progressively increased in bronchoalveolar lavage fluid after pulmonary adenovirus infection, and all were significantly elevated at 6 h (P < 0.05). To
begin to define the molecular mechanism(s) by which adenovirus
initiates the inflammatory signaling in macrophages, TNF-
expression
from adenovirus-infected RAW264.7 macrophages was evaluated in vitro.
TNF-
expression was readily detected in adenovirus-infected RAW cell
supernatant with kinetics similar to AM
during in vivo infection.
Blockage of virus uptake at specific cellular sites, including
internalization (by wortmannin), endosome acidification and/or lysis
(by chloroquine) or by Ca2+ chelation (by BAPTA) completely
blocked TNF-
expression. In conclusion, results showed that during
ARTI, (i) AM
rapidly internalized adenovirus, (ii) expression of
inflammatory mediators was initiated within AM
and not airway
epithelial or other cells, and (iii) the initiation of inflammatory
signaling was linked to virion uptake by macrophages occurring at a
point after vesicle acidification. These results have implications for
our understanding of the role of the AM
in the initiation of
inflammation following adenovirus infection and adenovirus-mediated
gene transfer to the lung.
 |
INTRODUCTION |
Adenovirus, a nonenveloped DNA virus
with at least 45 serotypes, is an important respiratory pathogen
affecting individuals of all ages and accounting for 7 to 10% of all
respiratory illnesses in infants and children, with an incidence of
between 5 to 10 million infections annually in the United States alone
(13, 21). Adenovirus respiratory tract infection (ARTI)
occurs sporadically, epidemically, and nosocomially, presents in a wide
spectrum of distinct clinical syndromes ranging from self-limited acute
pharyngitis to fatal pneumonia, and has been identified as an
etiological factor associated with exacerbations in individuals with
chronic obstructive lung diseases (13). Despite the
frequency and broad range of clinical presentations, the pathogenesis
of inflammation in ARTI is poorly understood. Early information
regarding host responses to adenovirus was derived from efforts to
develop human adenovirus vaccines (42) or to understand the
pathology of fatal adenoviral pneumonia (4). Recently, ARTI
has been studied in a variety of animal models, including mice
(14, 37, 58), Cotton rats (Sigmodon hispidus)
(15, 39, 59, 60), and primates (8, 44, 55, 61) as
part of preclinical toxicology studies for human gene therapy clinical
trials for cystic fibrosis (reviewed in references 7
and 48). Studies in humans showed that
administration of replication-deficient adenovirus vectors to the
respiratory tract can cause dose-dependent local inflammation (12,
26, 33).
Inflammatory responses to ARTI have been best studied in rodent models.
In the Cotton rat, a permissive host for replication of human
adenovirus, pulmonary histopathology consists of early and late phases
similar to that seen in human ARTI (15, 39). The early phase
consists primarily of accumulation of neutrophils, macrophages, and
monocytes and develops within the first 24 h (60). The
late phase, consisting mainly of lymphocytes, is apparent by day 5 (39, 60). In mice, a nonpermissive host for human adenovirus, adenovirus early gene expression occurs in the absence of
viral replication or late gene expression (14). Importantly, the histopathologic response is similar to that observed in Cotton rats
(14, 37, 39, 60) and humans (4) and inoculation of the respiratory tract with sufficient doses of either wild-type or
replication-deficient adenovirus results in significant pulmonary inflammation (14, 37). The earliest histopathological
abnormality, the influx of polymorphonuclear neutrophils (PMN), is
first noted 6 h after infection (37), peaks by 24 h, and evolves over the course of several days into a mononuclear cell
infiltrate due to influx of both CD4+ and CD8+
lymphocytes and expansion of the mononuclear phagocyte pool
(14, 37, 58). ARTI is accompanied by an evolving
pattern of elevated levels of proinflammatory cytokines (tumor necrosis
factor alpha [TNF-
], interleukin-6 [IL-6], IL-1, and
interferon gamma [IFN-
] and chemotactic chemokines
(macrophage inflammatory protein-1
[MIP-1
], MIP-2, and
macrophage chemotactic protein-1 [MCP-1]), the chronology of which
has been partially characterized in mice over the period from 6 h
to several weeks (14, 32, 37). TNF-
, IL-6, MIP-1
, and
MIP-2 are among the earliest proinflammatory molecular mediators
detected and are significantly elevated in lung lavage fluid at 6 h, while MCP-1, IL-1, and IFN-
are elevated by 24 h
(37). The pattern of molecular and cellular inflammation is
similar in both normal and immunodeficient (athymic) mice
(37), demonstrating that initiation of inflammatory
signaling is independent of specific (adaptive) immunity. However,
neither the precise location nor the mechanism of the initiation of
inflammatory signaling during ARTI is known. Such signalling might
occur in epithelial cells (which are tropic for the virus) or alveolar
macrophages or as a consequence of recruited natural killer or other cells.
Alveolar macrophages (AM
) can provide a barrier to pulmonary
infection through both intrinsic and extrinsic resistance pathways, the
former by their ability to accumulate pathogenic organisms by
phagocytosis and/or endocytosis and to degrade or restrict the
replication of the organism and the latter by the recruitment and
activation of other inflammatory cells and by their ability to act as
accessory cells in adaptive immune responses (6, 53).
Macrophages (M
) play a central role in the acute-phase response and
intrinsic resistance to some viruses, including vesicular stomatitis
virus, encephalomyocarditis virus, and influenza virus, while failing
to provide a barrier and instead providing a reservoir for latent
infection for other viruses such as human immunodeficiency virus
(reviewed in reference 53). Adenovirus is cleared
from the mouse lung in a biphasic pattern consisting of an early-phase rapid elimination of approximately 60% of the adenovirus DNA within the first 24 h, followed by a late-phase slower elimination of remaining adenovirus DNA over the course of several days to weeks (56). While the late-phase elimination is known to be due to the destruction of infected epithelial cells by adenovirus-specific cytotoxic T lymphocytes (58), the very rapid onset of the
early phase within the first day suggests a mechanism independent of adaptive immunity (56). This was confirmed by the finding of similar early-phase elimination kinetics in normal and immunodeficient (athymic) mice (56). Pretreatment of the lungs with
clodronate-laden liposomes to deplete phagocytic cells significantly
impaired early-phase clearance, suggesting that lung macrophages may
mediate the rapid adenovirus clearance. However, because rapid and
significant PMN influx occurs during the first 24 h of infection
(37), thus overlapping the early phase of adenovirus
elimination (56), PMN-mediated clearance cannot be excluded
as an important mediator of viral clearance in ARTI.
The mechanism by which phagocytic cells such as AM
might internalize
adenovirus in vivo is not known and might involve endocytosis or
phagocytosis and may also involve other factors in the local milieu.
The in vitro uptake of adenovirus by highly susceptible epithelial-like
cells has been well studied (reviewed in reference 17), occurs by receptor-mediated endocytosis
(31), and can be summarized as follows: (i) high-affinity
binding of the virion to the cell mediated by attachment of the
adenovirus fiber knob to its 46-kDa cell surface receptor, CAR
(5); (ii) receptor clustering and rapid virion
internalization via a clathrin-coated vesicle mediated by interaction
of the adenovirus penton base with integrins
v
5 or
v
3
(28-30, 52, 54); (iii) release of clathrin to generate an
endocytotic vesicle; (iv) endosome acidification mediated by an
endogenous vesicular membrane proton pump (38); (v)
penetration of the endosome membrane (endosome lysis) and release of
the virion into the cytoplasm mediated by the TVD motif-containing
cytoplasmic tail portion of integrin
5 (51);
(vi) virion translocation to the nuclear membrane mediated by
microtubules (28, 45); (vii) virion binding to the nuclear pore (16); (viii) capsid disassembly at the nuclear pore
(17); and (ix) translocation of viral chromatin into the
nucleus through the nuclear pore (16). The ability of
specific blocking agents to interrupt virion uptake at each of these
sites has provided the means to study the internalization mechanism in
detail (17). In contrast to highly susceptible
CAR+ cells, in vitro studies show that hematopoietic
lineage cells, including AM
, monocytes, and related cell lines,
which do not express CAR, internalize adenovirus about 100- to
1,000-fold less well (22, 23, 25, 49). Despite the very slow
uptake kinetics in vitro, internalization of adenovirus by such cells
in vitro requires cell surface
v integrin, similar to
CAR+ epithelial cells, and upregulation of
v
5 and
v
3
on human monocytes facilitates their infection by adenovirus
(22).
In this study, we hypothesized that AM
rapidly internalize
adenovirus in vivo very early during ARTI and then directly initiate inflammatory signaling. To test this hypothesis, we examined the immediate pulmonary distribution of adenovirus and internalization by
AM
during acute ARTI in vivo. Virion internalization was correlated with the kinetics and cellular origin of the earliest detectable stimulated proinflammatory cytokine responses. Adenovirus was very
rapidly internalized by AM
, and the earliest detectable cytokine
responses occurred in AM
and not airway epithelial cells as detected
by in situ hybridization. To begin to define the molecular mechanism(s)
whereby adenovirus stimulates inflammatory signaling in AM
during
internalization of the virion, we correlated virion uptake with TNF-
release from adenovirus-infected macrophages after interrupting virion
internalization at various sites with specific blockers. The data show
that TNF-
expression in adenovirus-exposed AM
is initiated by a
molecular mechanism activated during or subsequent to acidification of
the adenovirus-containing vesicle.
 |
MATERIALS AND METHODS |
Adenovirus.
The adenovirus used in this study was a human
serotype 5 adenovirus carrying a 2,936-bp deletion in E1, a 1,875-bp
deletion in E3, and a 3,932-bp lacZ marker gene within the
E1 deletion (for convenience referred to as adenovirus hereafter except
where otherwise specified) and has been previously described
(47). For the transduction experiment, Av1GFP, an adenovirus
of identical structure except expressing a mammalianized green
fluorescent protein (GFP) instead of the lacZ marker was
used. Viral growth in 293 cells, purification, and storage were done as
previously described (41) except that infection was carried
out in roller bottles (Falcon no. 3069) containing 12 × 107 cells/bottle and approximately five virions/cell in a
Wheaton roller bottle apparatus with continuous slow rotation in a
humidified atmosphere containing 5% CO2 at 37°C. All
cell culture media, medium supplements, and solutions used in virus
preparation were supplied routinely or by special arrangement as
endotoxin-free materials (BioWhittaker, Inc., Walkersville, Md.).
Adenovirus was prepared under conditions which have previously been
shown to yield undetectable levels of endotoxin using the
Limulus amebocyte assay (BioWhittaker, Inc.)
(55). The concentration of adenovirus virions was determined
from the optical density of the purified virus at 260 nm and is
expressed as optical particle units (OPU) as previously described
(35).
Mice.
Mice (BALB/c) were maintained in a "barrier"
facility in microisolation cages with filtered air under controlled
ventilation and constant temperature and humidity. Bedding, food, and
water were all sterilized before use, and food and water were
administered ad libitum. Sterilely gowned and gloved operators
performed cage changes and animal handling in a laminar flow biosafety
cabinet. Sentinel mice were tested monthly to ensure a pathogen-free environment.
Localization of adenovirus within the lung after in vivo
infection.
To permit visualization of adenovirus virions during in
vivo infection, purified adenovirus was labeled by covalent linking of
the fluorescent dye, FluoroLink Cy3 (Amersham, Inc.) essentially as
described by Leopold et al. (28). Virus labeling in this way
results in retention of greater than 90% virus infectivity (28). A molecular sieve chromatography step using PG10
columns (Bio-Rad, Inc.) was substituted for the final dialysis step to increase the purity of the labeled virions and to eliminate traces of
unlinked dye from the fluorescently labeled adenovirus (Ad-Cy3) preparations. Ad-Cy3 (4 × 1010 OPU) was administered
to lungs of normal mice by transtracheal instillation (63).
At subsequent times indicated in the figures, mice were anesthetized
with pentobarbital and either bronchoalveolar lavage (BAL; three times
with 1 ml of Hank's balanced salt solution (HBSS) containing 20 mM
EDTA) was done to collect cells or the lungs were fixed in situ at 25 cm of H2O, embedded in paraffin, and sections (5 µm) were
prepared. Specimens were evaluated by fluorescence microscopy (Nikon
FXTA microscope) or by confocal microscopy. Differential counts were
done for cells recovered by BAL after cytocentrifugation and Diff-Quick
(Dade Diagnostics, Inc.) staining as previously described
(37).
Evaluation of cytokine protein levels by ELISA.
Quantification of cytokine expression in murine lung following
adenovirus infection was done as previously described (37). Briefly, adenovirus (4 × 1010 OPU) was administered
by oral endotracheal delivery, and mice were sacrificed at various
subsequent times (0.5, 3, and 6 h) by pentobarbital injection
followed by exsanguination. BAL fluid was then collected as described
above, cleared of cells by centrifugation (200 × g, 5
min, 4°C), and stored at
80°C until use. Quantification of
cytokine and chemokine levels in unconcentrated BAL fluid was accomplished by enzyme-linked immunoassay (ELISA; Quantikine M kits;
R&D Systems, Minneapolis, Minn.) under conditions specified by the manufacturer.
Evaluation of cytokine mRNA expression by RT-PCR.
To
evaluate cytokine mRNA expression during ARTI, adenovirus (4 × 1010 OPU) was administered as described above. Mice were
sacrificed at subsequent times (0.5, 3, and 6 h) as described
above, and lungs were removed en bloc. Total RNA was purified by the
guanidine-acid phenol-guanidinium method, subjected to reverse
transcription-polymerase chain reaction (RT-PCR) amplification using
cytokine gene-specific oligonucleotide primers (1), and
evaluated by agarose gel electrophoresis as previously described
(37). To evaluate cytokine and chemokine mRNA expression in
recovered murine AM
, mice were infected and sacrificed as described
above. AM
were recovered by BAL and collected by centrifugation
(200 × g, 5 min, 4°C), total RNA was purified with a
Micro-Scale RNA Prep Kit (5 Prime-3 Prime, Inc.), and RT-PCR was
carried out as described elsewhere (37).
Localization of in vivo mRNA expression by in situ
hybridization.
To localize expression of proinflammatory cytokine
mRNA to specific cell types within the lung, mice were infected with
adenovirus (4 × 1010 OPU/mouse). At subsequent times
(30 min, 3 h, and 6 h), mice were sacrificed, and lung tissue
was processed and evaluated by in situ hybridization with
35S-labeled cRNA antisense and sense (control) probes as
previously described (62). Briefly, IL-6 cRNA riboprobe
synthesis was performed using a 664-bp murine IL-6 cDNA (kindly
provided by Keiko Yamauchi Takihara, Osaka, Japan) subcloned into pSP72
(Promega, Inc.). TNF-
cRNA riboprobe synthesis was performed with a
1,101-bp murine TNF-
cDNA subcloned into pGEM7Z+
(Promega, Inc.). Both antisense (for mRNA detection) and sense (as a
control for nonspecific hybridization) [35S]UTP (specific
activity, 1,000 to 1,500 Ci/mmol)-labeled cRNA probes were synthesized
in vitro from opposing transcriptional promoters using the Riboprobe
Gemini Core System II transcription kit under conditions specified by
the manufacturer (Promega, Inc.). Tissue sections were incubated at
42°C (IL-6) or 55°C (TNF-
) overnight in hybridization buffer (15 µl) containing 106 cpm of purified probe and 50%
formamide. Following hybridization, tissues were washed to a final
stringency of 0.1× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium
citrate), and autoradiography was performed using Kodak NTB2 emulsion
at 4°C for periods of 3 to 8 weeks. Development was done with Kodak
D19 developer as previously described (62). Representative
examples of hybridization results were photographed with dark-field
illumination and then counterstained with hematoxylin and eosin for
bright-field or phase microscopy using a Nikon Microphot-FXA microscope.
Evaluation of adenovirus-induced cytokine induction in murine
macrophages.
To further explore the adenovirus-macrophage
interactions that lead to induction of proinflammatory cytokine
expression, in vitro studies were conducted with a murine macrophage
cell line, RAW264.7 (American Type Culture Collection) (34).
These cells have phagocytic properties and the capacity to secrete
cytokines in response to adenovirus infection similar to that of
primary AM
. Cells were maintained in Dulbecco modified
Eagle medium (DMEM) supplemented with 10% heat-inactivated (56°C, 30 min) fetal bovine serum, 2 mM glutamine, 100 U of penicillin per ml,
and 100 µg of streptomycin per ml (DMEM-10) in a humidified
atmosphere containing 5% CO2 at 37°C. The culture medium
was changed every 2 to 3 days, and cells were passed using brief
trypsin digestion just prior to reaching confluence. To evaluate
adenovirus-stimulated macrophage TNF-
expression, cells were seeded
at 106 cells per well in six-well plates and incubated (16 h, humidified atmosphere, 5% CO2, 37°C). Cells were then
briefly exposed to adenovirus (5 × 1010 OPU/well, 30 min), after which the medium was aspirated and replaced with DMEM-10
without virus. TNF-
release into the medium was then quantified by
removing small aliquots (100 µl) of supernatant at subsequent times
and quantitative determination of TNF-
concentration by ELISA. To
determine at which step of adenovirus uptake TNF-
signaling is
initiated, virion uptake was blocked at one of several distinct
cellular sites, and then TNF-
release was quantified in supernatant
2 h after the start of infection. To evaluate the effect of
blocking adenovirus internalization at the stage of phagosome closure,
wortmannin, in various concentrations (0 to 300 µM) was preincubated
(15 min prior to infection) with cells, followed by adenovirus
infection and evaluation of TNF-
release as described above. As an
additional approach to block virion entry at the cell membrane, cells
were incubated at 4°C for 10 min prior to and during adenovirus
infection. At subsequent times (1 to 6 h), cells were warmed to
37°C (removal of "cold block"), incubation was continued, and the
TNF-
assay was done as described above. In experiments designed to
evaluate the role of Ca2+ signaling in
adenovirus-stimulated TNF-
release, cells were preincubated (30 min
prior to adenovirus infection) in the absence or presence of 100 µM
bis-(o-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid (BAPTA) to block intracellular Ca2+ flux. Adenovirus
infection and TNF-
expression were evaluated as described above.
Chloroquine, which blocks the cellular pathway of adenovirus uptake at
the endosome by blocking endosome acidification (17, 43),
was used to evaluate the effect of blocking virion entry at the stage
of endosome lysis. Chloroquine (50 or 100 µM) was preincubated (10 min prior to infection) with cells, followed by adenovirus exposure and
evaluation of TNF-
release as above. Trypan blue exclusion was used
to assess the potential for toxicity from each of the inhibitors under
each of the conditions used: in every condition, cell viability was
greater than 97% at the end of the experimental period (2 h after the
start of infection).
Statistical method.
Numerical data are presented as the
mean ± the standard error of the mean. Statistical comparisons
were made by using the Student's t test using Sigma Plot
(v4.0) software on an IBM-compatible microcomputer.
 |
RESULTS |
Intrapulmonary distribution and fate of virions during early
adenovirus lung infection.
To directly determine the distribution
and immediate fate of adenovirus following intrapulmonary
administration, adenovirus labeled with the fluorescent dye, Cy3
(Ad-Cy3) was administered (4 × 1010 OPU/mouse) by
tracheal instillation. Localization of Ad-Cy3 by fluorescence
microscopy of unstained, paraffin-embedded sections revealed that
adenovirus was rapidly and widely distributed throughout the
respiratory tract (Fig. 1). Within medium
and larger airways, virus was seen along the airway epithelial surfaces
at approximately 1 min with little penetration into the lung parenchyma
(top left panels). By 10 min, virus was observed in a punctate pattern
in association with macrophages in the tissue near the terminal airways (top right panels). Fluorescence remained associated with the airway
lumen and within nearby macrophages at later times (3 and 6 h;
data not shown). In alveolar spaces, Ad-Cy3 was initially (~1 min)
distributed predominantly in a "point-like" pattern, suggesting
fine dispersion of the virions (middle left panels). By 10 min,
adenovirus was found in a more punctate pattern associated with
AM
(middle right panels). The punctate pattern of
macrophage-associated fluorescence persisted at subsequent times (3 and
6 h) and became more pronounced, suggesting further accumulation
in AM
(data not shown). Cells obtained by BAL revealed
accumulation of Ad-Cy3 as early as 1 min after adenovirus instillation
(bottom left panels). Accumulation was pronounced by 10 min (bottom
right panels) and progressed substantially through the 6-h period of
observation (30 min and 3 and 6 h; data not shown). BAL cells from
adenovirus-infected mice contained greater than 95% macrophages at all
times after infection up to 6 h as determined by Diff-Quick
staining and differential counting (P > 0.36 for all
comparisons of AM
values at 30 min, 3 h, and 6 h; Table
1). However, neutrophils were
occasionally seen at 30 min and began to increase in number at 3 and
6 h (without reaching statistical significance [P > 0.6, all comparisons]), a result consistent with the patchy
histological evidence of neutrophil infiltration at 6 h as
previously observed (37). Confocal microscopy revealed the
presence of Ad-Cy3 within AM
recovered by BAL and, interestingly, also within occasional PMN recovered at 6 h (data not shown). These data show that during ARTI in mice, adenovirus is
initially widely distributed throughout the respiratory tract and that
adenovirus rapidly accumulates within AM
.

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 1.
Distribution of adenovirus during acute respiratory
tract infection. Infectious, fluorescently labeled adenovirus (Ad-Cy3)
or HBSS, as a sham control, was administered by intratracheal
instillation into the lungs of mice. Mice were then sacrificed after
either 1 min (left panels) or 10 min (right panels), and the lungs were
removed and processed for tissue sections or the mice were subjected to
BAL, followed by recovery and cytospin preparation of cells as
described in Materials and Methods. Shown are fluorescence and
corresponding phase photomicrographs for tissue sections (top and
middle panels, ×114) and fluorescence and bright-field
photomicrographs for BAL cells (bottom panels, ×232). For BAL cells,
separate slides were prepared for fluorescence and bright-field
photomicroscopy because Diff-Quick staining partially quenched Cy3
fluorescence.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Differential cell counts for BAL cells recovered at
various times from mice receiving intrapulmonary administration
of adenovirusa
|
|
Early molecular inflammation induced by adenovirus lung
infection.
To identify some of the molecular mediators that
initiate the cascade of pulmonary inflammation that occurs during ARTI,
we measured the level of several important proinflammatory and
chemotactic molecular mediators in unconcentrated BAL fluid obtained
0.5, 3, and 6 h after adenovirus administration to the lung (Fig.
2). IL-6, TNF-
, MIP-2, and MIP-1
were all significantly elevated in unconcentrated BAL fluid obtained
from adenovirus-exposed mice by 6 h after infection (P < 0.05, all comparisons to controls; Fig. 2). TNF
, MIP-2, and
MIP-1
, but not IL-6, were also elevated at 3 h. None of these
cytokines were yet detectable 30 min after infection. As a sham
administration control, mice exposed to HBSS did not show detectable
cytokine or chemokine activity at any time (Fig. 2). To determine if
adenovirus infection increased cytokine levels by stimulating gene
expression, mRNA levels for these cytokines were measured in whole lung
total RNA by RT-PCR as previously described (37). Cytokine
mRNA transcripts were easily detected in the lungs of mice 3 and 6 h after adenovirus exposure and variably detected 30 min after
adenovirus exposure (data not shown, but see below [Fig. 6] for
evaluation of expression in isolated AM
). In contrast, mice exposed
to HBSS as a sham control did not have detectable mRNA for IL-6,
TNF-
, MIP-2, and MIP-1
at any time (0, 30 min, 3 h, or
6 h; data not shown). These results show that initiation of the
inflammatory cascade occurs very early during ARTI and is associated
with activation of cytokine gene expression.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 2.
Stimulation of proinflammatory cytokine and chemotactic
chemokine levels in lung during acute adenovirus respiratory tract
infection. Infectious adenovirus (+Ad) or HBSS (Control) was
administered by intratracheal instillation into the lungs of mice
(n = 3/time point). At the subsequent times indicated,
mice were sacrificed and the lung epithelial lining fluid was recovered
by BAL. Proinflammatory cytokine (IL-6 and TNF ) and chemoattractive
chemokine (MIP-2 and MIP-1 ) levels were measured in unconcentrated
BAL fluid by ELISA. The entire experiment was performed twice, and
representative data from one experiment are shown.
|
|
Localization of proinflammatory cytokine mRNA expression during
early adenovirus lung infection.
To determine a cell source of
adenovirus-stimulated proinflammatory cytokine gene expression,
expression of cytokine (IL-6, TNF-
) mRNA was evaluated by in situ
hybridization. Six hours after infection, hybridization was detected in
lung parenchyma with a 32P-labeled IL-6 cRNA antisense
probe (Fig. 3, upper left panels). As a
negative control for nonspecific probe binding, a
32P-labeled IL-6 cRNA sense probe did not show
hybridization in lungs of virus-infected mice (upper middle panels). As
a negative sham administration control, the antisense probe did not
show hybridization in the lungs of mice exposed to HBSS instead of adenovirus (upper right panels). Detailed evaluation of
adenovirus-infected lungs revealed intense hybridization of the IL-6
antisense probe in AM
(lower left panels) but not airway
epithelial cells (lower middle panels) or vascular endothelial cells
(lower right panels). A similar pattern of expression was observed for
TNF-
6 h after infection (Fig.
4). Specific hybridization was observed
only to a 32P-labeled TNF-
cRNA antisense probe in the
lung parenchyma of virus-infected mice (left panels). As a negative
control for nonspecific probe binding, no hybridization was observed
when a 32P-labeled TNF-
cRNA sense probe was incubated
with lung parenchyma from virus-infected mice (middle panels) or with
the antisense probe in sham HBSS administration control mice (right
panels). Detailed evaluation of adenovirus-infected lung tissues showed hybridization of the TNF-
antisense probe in AM
but in
not the airway epithelium or vascular endothelium. IL-6 and TNF-
antisense probes both showed specific hybridization to AM
within lung parenchyma obtained 30 min after virus administration (Fig.
5). Neither IL-6 nor TNF-
antisense
probes hybridized to airway epithelium or vascular endothelium of
virus-infected mice at 30 min. As negative controls for nonspecific
probe binding, neither IL-6 nor TNF-
sense probes showed
hybridization to lung tissues of virus-infected mice at 30 min (data
not shown but similar to that presented in Fig. 3 and 4, upper middle
panels). Neither IL-6 nor TNF-
antisense probes hybridized to
negative sham administration controls taken at 30 min (data not shown
but similar to that presented in Fig. 3 and 4, upper right panels).
Similar results were obtained with these probes using lung parenchyma
taken at 3 h (data not shown). These results demonstrate readily
detectable expression of proinflammatory genes (e.g., IL-6 and TNF-
)
by 30 min and further localize this expression to AM
.

View larger version (129K):
[in this window]
[in a new window]
|
FIG. 3.
Localization of IL-6 mRNA expression by in situ
hybridization in lung tissues 6 h after adenovirus respiratory
tract infection. Infectious adenovirus or HBSS was administered by
intratracheal instillation into the lungs of mice. After 6 h, mice
were sacrificed, and the lungs were removed, inflation fixed, and
subjected to in situ hybridization analysis using IL-6-specific
35S-labeled antisense and sense cRNA probes as described in
Materials and Methods. (Upper panels) Dark-field (above) and
bright-field (below) views of the hybridizations of lung tissues from
adenovirus-infected or sham control (HBSS)-exposed mice with antisense
or sense probes (indicated). The bronchial epithelium (br) and vascular
endothelium (v) are indicated. The sense probe did not show specific
hybridization in HBSS-exposed mouse lung (not shown but similar to
results for sense probe [middle panels] in adenovirus-infected mice).
(Left and middle panels, ×143; right panels, ×286). (Lower panels)
High-power dark-field (above) and bright-field (below) views
demonstrating hybridization of the antisense probe to lung tissues from
adenovirus-infected mice. Bronchial and vascular tissues are indicated
for upper panels (×343).
|
|

View larger version (80K):
[in this window]
[in a new window]
|
FIG. 4.
Localization of TNF- mRNA expression by in situ
hybridization in lung tissues 6 h after adenovirus respiratory
tract infection. Mice were exposed to adenovirus or HBSS and then
sacrificed and prepared for in situ hybridization as described in the
legend to Fig. 3. Tissues were hybridized with TNF- -specific
35S-labeled antisense and sense cRNA probes. Dark-field
(above) and bright-field (below) views of the hybridizations of lung
tissues from adenovirus-infected or sham control (HBSS)-exposed mice
with antisense or sense probes (indicated) are shown. The bronchial
epithelium (br) and vascular endothelium (v) are indicated. The sense
probe did not show specific hybridization in HBSS-exposed mouse lung
(not shown but similar to sense probe [middle panel] in
adenovirus-infected mice). (Left and middle panels, ×143; right
panels, ×286).
|
|

View larger version (102K):
[in this window]
[in a new window]
|
FIG. 5.
Localization of IL-6 and TNF- mRNA expression by in
situ hybridization in lung tissues 30 min after adenovirus respiratory
tract infection. Mice were exposed to adenovirus or HBSS and then
sacrificed and prepared as described in the legend to Fig. 3 except
that lung tissues were recovered 30 min after initiation of infection.
In situ hybridization was done using TNF- or IL-6-specific
35S-labeled antisense or sense cRNA probes as described
above. Results for mice infected with adenovirus for 30 min after
hybridization to antisense probes for IL-6 (left panels) or TNF-
(right panels) are shown. For each field, both dark-field (above) and
bright-field (below) views are shown. Note the hybridization in
AM (arrows) but not in the bronchial (br) epithelium or
the vascular (v) endothelium. The results for the sense probe and HBSS
sham infection controls are shown in Fig. 3 and 4 (experiments
conducted simultaneously). Magnification, ×430.
|
|
Proinflammatory cytokine mRNA expression in AM
recovered early after adenovirus lung infection.
To confirm that
AM
were a source of stimulated expression of
proinflammatory cytokines and chemotactic chemokines in the lungs of
adenovirus-exposed mice, BAL cells were recovered after infection and
evaluated by RT-PCR. At 3 and 6 h after adenovirus administration
to the lung, IL-6, TNF-
, MIP-2, and MIP-1
mRNA transcripts were
consistently detected at elevated levels in BAL cells from
adenovirus-infected mice but not in sham, HBBS-exposed controls (Fig.
6). TNF-
, IL-6, MIP-2, and MIP-1
mRNA transcripts were also detectable in BAL cells recovered from
virus-infected mice after only 30 min (Fig. 6). Although consistently
detected at later times, at 30 min expression was variably detectable
in independent experiments, suggesting that 30 min is approximately the
time of the initiation of expression. Since AM
comprised more than 95% of the recovered BAL cells for up to 6 h after
adenovirus infection in this study (Table 1), the RT-PCR data confirm
that AM
were the likely source of the rapidly upregulated
proinflammatory cytokine and chemotactic chemokine mRNA levels during
ARTI. Taken together, these data demonstrate that AM
begin to take up adenovirus immediately after in vivo lung infection,
upregulate cytokine and chemokine mRNA levels within minutes, and are
the source of the earliest detectable cytokine signals in the
initiation of the pulmonary inflammatory cascade during ARTI.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 6.
Stimulation of proinflammatory cytokine mRNA levels in
AM recovered after adenovirus respiratory tract
infection. Mice were exposed to adenovirus (Ad) or HBSS (Control) and
sacrificed at subsequent times (indicated), and RT-PCR analysis was
done as described in Materials and Methods. All experiments were
conducted twice and results from experiment 1 (IL-6) or experiment 2 (TNF- , MIP-2, MIP-1 , and L32) were chosen so as to permit
adequate photographic reproduction of the data at 30 min. Each lane
represents data from a separate mouse.
|
|
Mechanism of adenovirus-stimulated initiation of macrophage
proinflammatory cytokine stimulation.
To begin to define the
molecular mechanism(s) whereby clearance of adenovirus by macrophages
stimulates acute-phase, proinflammatory cytokine expression,
adenovirus-stimulated TNF-
expression from the macrophage cell line,
RAW264.7, was evaluated in vitro. Preliminary experiments showed that
these cells were able to internalize adenovirus and rapidly responded
by secretion of TNF-
with kinetics similar to those of
AM
. Further, the in vitro approach permitted precise control of the experimental conditions required to block virion uptake
into cells at various sites (17). We hypothesized that by
blocking virion uptake, the molecular stimulus that initiates inflammatory cytokine signaling (e.g., TNF-
) could also be blocked. Ad-Cy3 was used to verify, by direct visualization, that adenovirus entry could be blocked at various specific cellular sites, as expected
based on studies of adenovirus uptake and uncoating in epithelial cells
(16, 17, 22, 23, 29, 30, 38, 43) (Fig.
7). Exposure of RAW264.7 cells to Ad-Cy3
in vitro resulted in a pattern of fluorescence demonstrating
significant virus internalization, cytoplasmic translocation, and
prominent extranuclear aggregation (Fig. 7A). As expected
(16), incubation of virus and cells at 4°C prevented
virion internalization, resulting in a pericellular rim of Ad-Cy3
fluorescence (panel C). Evaluation by confocal microscopy confirmed
that virion entry into the cell was blocked at 4°C but not at 37°C
(panels B and D). The intracellular calcium chelator BAPTA did not
prevent virion attachment or internalization. However, little or no
translocation and no significant extranuclear aggregation of
fluorescence was noted in BAPTA-treated cells by either fluorescence or
confocal microscopy (panels E and F). As expected, wortmannin, a
specific blocker of phosphatidylinositol 3-OH kinase (PI3K) (46), phagocytosis (3), and adenovirus
internalization (30), did not block virion attachment to the
cell surface (panels G and H), but virions were poorly internalized and
did not localize as large extranuclear aggregations of fluorescence as
seen in untreated cells (panels A and B). Chloroquine, which blocks
endosome acidification (43) and adenovirus uptake at the
doses used here (17), did not prevent virus attachment or
internalization but did reduce the extranuclear aggregation of
fluorescence (panels I and J).

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 7.
Direct visualization of uptake of adenovirus virions by
cultured macrophages in vitro and blockage of uptake at distinct
stages. Ad-Cy3 was incubated with RAW264.7 cells under various
conditions, and the results were evaluated by fluorescence (A, C, E, G,
and I) and confocal (B, D, F, H, and J) microscopy as described in
Materials and Methods. (A and B) Infection at 37°C. (C and D)
Infection at 4°C. (E and F) Effect of the Ca2+ chelator,
BAPTA, on the cellular distribution of virions during infection at
37°C. (G and H) Effect of wortmannin, a PI3K inhibitor known to block
adenovirus endocytosis. (I and J) Effect of chloroquine, a
lysosomotropic agent know to block endosome acidification. All panels,
×706.
|
|
To assess the fate of adenovirus in macrophages subsequent to
extranuclear aggregation, we evaluated adenovirus-mediated nuclear
gene
transfer and expression in AM

, RAW264.7 macrophages and,
as an epithelial-like cell positive control, A549 cells using
Av1GFP.
As expected, A549 cells were very efficiently transduced,
and nearly
all cells expressed GFP when evaluated 48 h after infection
by
using flow cytometry to quantify GFP-positive cells (Fig.
8,
A549). In contrast, transduction of
murine AM

was very inefficient,
with only 0.2% of cells showing an
increase in mean fluorescence
by flow cytometry (Fig.
8, AM

).
Similarly, RAW264.7 macrophages
were also poorly transduced, with only
0.02% of cells showing
an increase in mean fluorescence (Fig.
8, RAW).
Evaluation of
transduced cells by fluorescence microscopy demonstrated
that,
while nearly all A549 cells expressed GFP, none of the infected
alveolar or RAW264.7 macrophages expressed GFP (data not shown).
These
results show that the ultimate fate of internalized adenovirus
is
different in macrophages and the nonphagocytic A549 cells and
is
consistent with inefficient nuclear delivery of the adenovirus
genome in M

.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 8.
Analysis of adenovirus-mediated transgene delivery and
expression. AM , RAW264.7 macrophages, or A549 cells, as
an epithelial-like cell positive control, were infected with Av1GFP, an
adenovirus vector similar in structure to Av1nBg except expressing a
mammalianized GFP encoding transgene. After 48 h, cells were
evaluated for GFP expression by quantifying fluorescence using flow
cytometry (gray profiles). Uninfected control cell samples were also
evaluated (black profiles).
|
|
To assess the mechanism of adenovirus-stimulated macrophage cytokine
expression, studies were conducted using RAW264.7 macrophages
infected
in vitro by adenovirus in the absence or presence of
various conditions
known to block virion entry into cells at various
sites along the
pathway (
17) (
30). Adenovirus exposure produced
a
brisk, reproducible stimulation of TNF-

expression in RAW264.7
cells, resulting in easily detectable levels of TNF-

in the media
at
2 h (Fig.
9; see Fig.
11 below for
the time course of expression).
In Ca
2+-free medium,
adenovirus exposure resulted in marked TNF-

release
at 2 h,
while unexposed controls did not release any detectable
TNF-

(panel
A, +Ad). Results were similar in Ca
2+-containing medium
except that TNF-

release was increased (panel
B, +Ad). To
investigate the role of Ca
2+ in the mechanism of
adenovirus-stimulated TNF-

expression, RAW264.7
cells were infected
in the absence or presence of the intracellular
Ca
2+
chelator BAPTA. Preincubation of cells with BAPTA completely
blocked
TNF-

release from adenovirus-exposed cells in both
Ca
2+-free (panel A, +BAPTA +Ad) and
Ca
2+-containing (panel B, +BAPTA +Ad) medium. As a positive
control,
to demonstrate the role of extracellular Ca
2+
influx in TNF-

expression by RAW264.7 cells, the Ca
2+
ionophore, A23187 stimulated a large TNF-

release in
Ca
2+-containing medium (panel B, +A23187). As a negative
control for
effect of this Ca
2+ ionophore on TNF-

expression, as expected, TNF-

release did
not occur in response to
A23187 in Ca
2+-free media (panel A, +A23187). As a positive
control for the
blocking effects of BAPTA, the marked release of
TNF-

occurring
in cells exposed to a known potent TNF-

-releasing
stimulus (lipopolysaccharide
plus A23187) was blocked completely by
BAPTA in both Ca
2+-free and Ca
2+-containing
medium (+BAPTA +LPS +A23187). These observations show
that
adenovirus-stimulated TNF-

release by RAW264.7 macrophages
is
dependent on Ca
2+ and that this flux can derive from both
intra- and extracellular
sources.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 9.
Adenovirus-stimulated macrophage TNF- expression in
vitro does not occur in the presence of the Ca2+ chelator,
BAPTA. RAW264.7 cells were evaluated for TNF- expression and release
2 h after a 30-min in vitro exposure to adenovirus. All
experiments were carried out in the absence (A) or presence (B) of
Ca2+ in the culture medium. Cells were infected with
adenovirus alone (+Ad) or in the presence of the intracellular
Ca2+ chelator, BAPTA (+BAPTA +Ad) to demonstrate the effect
of blocking intracellular calcium fluxes on adenovirus-stimulated
TNF- expression. Cells were exposed to HBSS (Control) alone as a
negative control for spontaneous TNF- release. Cells were treated
with the calcium ionophore, A23187 in Ca2+-free or
Ca2+-containing medium as controls to demonstrate the role
of the extracellular Ca2+ in stimulation of TNF-
expression in RAW264.7 cells. As an additional positive control, cells
were exposed to lipopolysaccharide and A23187 (+ LPS + A23187), a
potent stimulus for TNF- expression in RAW264.7 cells. As an
additional control to demonstrate the blocking effect of BAPTA,
LPS-A23187 stimulation was done in the presence of BAPTA (+BAPTA +LPS
+A23187).
|
|
To determine if the signal for TNF-

release during adenovirus uptake
by RAW264.7 cells occurred before or after virion internalization,
wortmannin was used to block virion internalization (Fig.
7D).
Wortmannin blocked adenovirus-stimulated TNF-

release in a
dose-dependent
manner (Fig.
10). To
further assess virion internalization in the
mechanism of
adenovirus-stimulated TNF-

release by macrophages,
cold-induced
blockade of virion uptake was evaluated (
17). Incubation
of
virus with cells at 4°C blocked virion internalization, but
not cell
binding (Fig.
7B) as previously described (
17), and
completely blocked TNF-

expression for the duration of the
experiment
(data not shown). When cells were allowed to bind adenovirus
at
4°C and subsequently (after 1, 2, 3, and 6 h) warmed to
37°C,
TNF-

release was delayed by an amount related to the time of
the shift to 37°C and not the total time from the start virus
exposure (data not shown). Thus, TNF-

release by adenovirus-exposed
macrophages was correlated with virion internalization, and
virion
binding to the cell surface in the absence of internalization
was insufficient for TNF

release. Together, these observations
show
that TNF-

release is initiated by a molecular mechanism
subsequent
to internalization of the virion into the cell, but
not by virion
binding to the cell alone.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 10.
Adenovirus-stimulated macrophage TNF- expression
does not occur when virion internalization is blocked by wortmannin.
RAW264.7 cells were infected by adenovirus in vitro in the absence or
presence of various concentrations of the PI3K inhibitor, wortmannin,
and TNF- expression was measured at 2 h as described in
Materials and Methods.
|
|
To determine if the initiation of TNF-

release occurs before or
after endosome acidification, cells were incubated in the
absence or
presence of chloroquine under conditions known to block
endosome
acidification (
17,
43). Chloroquine completely blocked
adenovirus-stimulated TNF-

release at two different doses (50
and
100 µM) (Fig.
11).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 11.
Adenovirus-stimulated macrophage TNF- expression
does not occur when endosome acidification is blocked by chloroquine.
RAW264.7 cells were infected by adenovirus in vitro in the absence or
presence of two concentrations of chloroquine to block
endosome-lysosome acidification, and TNF- release into the culture
medium was measured at various subsequent times as described in
Materials and Methods.
|
|
Taken together, these data suggest that the signal for initiation of
TNF-

expression during adenovirus exposure to macrophages
requires
virion internalization, likely occurs during or subsequent
to
endosome acidification, and is calcium
dependent.
 |
DISCUSSION |
In the current study, we sought to obtain information regarding
the mechanism of initiation of the pulmonary inflammatory signaling
during adenovirus respiratory tract infection. Our results demonstrate
that adenovirus is rapidly distributed throughout the mouse lung and is
also very quickly internalized by alveolar macrophages in vivo.
Concurrently, inflammatory cytokine signaling is initiated in AM
but
not in airway epithelial or vascular endothelial cells. Finally, the
mechanism of macrophage-mediated TNF release requires internalization
of the virion and is calcium dependent.
An important focus of these studies was the determination of the in
vivo fate of adenovirus during ARTI. Adenovirus was already widely
distributed throughout airway and alveolar epithelial surfaces following intratracheal instillation at the earliest times feasible for
direct evaluation and was rapidly taken up by AM
. This very rapid in
vivo uptake of adenovirus by AM
is surprising for several reasons.
First, AM
and other hematopoietic lineage cells do not express the
high-affinity adenovirus receptor CAR (22, 23, 25, 49), and
thus in vitro virion binding is reduced ca. 100-fold compared to
CAR+ cells (9). Reintroduction of CAR into AM
significantly increased adenovirus binding and the rate of infection in
vitro (25). Second, monocytes and monocytic cell lines
express the coreceptor,
v
5 integrin, at
low levels, thus reducing adenovirus internalization (22).
Third, the rate of adenovirus infection in vitro is slow even in highly
susceptible cells that express CAR due to the rate-limiting step of
extracellular diffusion of virions to the cell surface (35).
Taken together, these observations suggest the possibility that an
additional factor may accelerate internalization of adenovirus by AM
in vivo. There are multiple candidates for such a factor, including
complement proteins or natural antibodies, which are important in the
uptake of some viruses (53), and collectins such as
surfactant proteins A and D, which are involved in lung host defense
(11). Such a role for surfactant proteins is supported by
data from mice genetically deficient in surfactant protein A expression
that show reduced in vivo adenovirus uptake by AM
during ARTI
(19). Interactions between surfactant and adenovirus are
also supported by data showing that coadministration of surfactant with
an adenovirus vector expressing a marker gene resulted in a wider
distribution of infection and gene transfer within the lungs of rabbits
(24). In vivo uptake and internalization adenovirus by AM
may also be facilitated by the expression of
v
5 integrins because adenovirus uptake
into most, if not all, other cells, including monocytes, requires
v
5 or
v
3
integrin, and upregulation of
v
5 integrin
expression on monocytes correspondingly increases their rate of
infection by adenovirus in vitro (22). The precise mechanism
of virion uptake by AM
in vivo is not known and may involve
endocytosis, phagocytosis, or both; further studies are needed to
determine the mechanism.
Our results are consistent with earlier studies (56) that
proposed a role for AM
in the clearance of adenovirus from the lung.
However, a role for PMN-mediated adenovirus uptake and clearance from
the lung has not been excluded. Importantly, our direct observations using confocal microscopy demonstrated that AM
and PMN both
internalize adenovirus during ARTI. Thus, further studies will be
required to determine the relative contributions of AM
and newly
recruited PMN in the clearance of adenovirus from the lung. Very little (<5%) of the internalized adenovirus is eliminated by lysosomal degradation in highly susceptible cells (e.g., epithelial cells) (17, 56). In contrast, AM
degrade a large proportion of
adenovirus administered in vivo (56). Further, although
AM
rapidly can internalize adenovirus in vivo, they are transduced
with very low efficiency. Thus, the pathway and fate of adenovirus in
AM
and epithelial cells appears to be fundamentally different or a
common pathway may diverge at a point after endosome formation. Alternative pathways for adenovirus infection have been shown in
fibroblasts in the absence or presence of CAR expression
(20). The notion that AM
efficiently degrade adenovirus
is not supported by data showing that adenovirus can persistently
infect hematopoietic lineage cells, including monocytes, thus providing
a reservoir for latent infection (2, 9). Also inconsistent
is the finding that AM
can harbor replication-deficient adenovirus
vectors for up to 5 weeks in immunocompetent mice in vivo
(57).
The major focus of the present study was to obtain information
regarding the mechanism of activation of the pulmonary inflammatory signaling during ARTI. The sequence of inflammatory events at late
times following adenovirus infection of the lung has been best studied
in animal models and consists of an evolving cascade of molecular and
cellular mediators (14, 37, 44, 55, 58, 60, 63). In mice,
cellular infiltration by PMN is noted in the lung as early as 6 h
after adenovirus administration (37). This increases in
magnitude, eventually giving way to a predominantly mononuclear cell
infiltrate over the course of several days. Elevated levels of several
proinflammatory cytokines and chemokines have also been observed at
intermediate times during ARTI. For example, elevated lung cytokine
levels were detected during ARTI for TNF-
, IL-6, MIP-1
, and MIP-2
in mice (37), IL-8 in nonhuman primates (55), and
IL-6 in humans (33). In humans, exposure of the adenovirus
to AM
was postulated as the cause of elevated IL-6 levels
(33). Consistent with this concept, following reduction of
the volume of adenovirus inoculum to prevent alveolar spread of virus
(thus reducing exposure to AM
), subsequently treated patients did
not show elevated IL-6 levels (33). In the present study,
TNF-
was detectable 3 h after adenovirus infection, and IL-6
was detectable at 6 h. Importantly, in situ hybridization demonstrated elevated mRNA levels for both cytokines in macrophages at
30 min, suggesting a common, very early activation signal. NF-
B
could provide such a signaling mechanism, and this factor has been
reported to be required for stimulation of TNF-
expression in AM
(27). Nonetheless, no mRNA expression for either cytokine was observed in airway or vascular endothelia, thus clearly identifying AM
as the site of initiation of the pulmonary
inflammatory cytokine cascade. Our results are consistent with in vitro
data that showed that cultured human bronchial epithelial cells do not
secrete cytokines after adenovirus exposure even though TNF-
, as a
positive control, stimulated IL-6 and IL-8 expression (36).
Several lines of evidence suggest that inflammation during ARTI is
initiated within AM
during virion uptake and/or degradation rather
than as a response of natural killer or other cells to infected
epithelial cells or by events within epithelial or vascular cells. In
vivo, adenovirus infection increased levels of TNF-
mRNA in AM
by
30 min and protein in BAL by 3 h. RAW264.7 macrophages infected at
high multiplicity in vitro showed similar TNF-
expression kinetics
and demonstrated that macrophages alone are sufficient for initiation
of cytokine signaling. Further, TNF-
expression was completely
abrogated when virion internalization was interrupted at one of several
distinct cellular sites. Previous studies have demonstrated that
receptor-mediated adenovirus internalization by epithelial cells is
blocked by wortmannin or infection at 4°C (17, 30). Both
of these conditions completely blocked adenovirus internalization and
TNF-
expression. Blocking intracellular Ca2+ flux
completely abrogated TNF-
expression by RAW264.7 cells. Although
BAPTA did not affect virion internalization, it prevented late
extranuclear aggregation of adenovirus. Ca2+ is known to be
involved in adenovirus uptake in CAR-expressing epithelial cells at
early and late times (16). Although the precise point of the
early involvement is not known, the later involvement occurs during
virion binding to the nuclear pore (16). It is interesting
that BAPTA enhanced adenovirus-mediated gene transfer to airway
epithelium during in vivo administration to the lung (50).
This enhancement was attributed to an effect on airway cell tight
junction permeability, although potential effects on macrophage virion
uptake were not evaluated. Chloroquine, at the doses used here, has
been shown to block endosome-lysosome acidification (38) and
also adenovirus-mediated endosome lysis and cellular infection
(17). At lower doses (5 to 10 µM) which reduce the
toxicity seen at late times (48 to 72 h) after infection, chloroquine was reported to block endosome acidification but did not
affect adenovirus infection of HeLa cells (40). Our data demonstrated that chloroquine completely blocked TNF-
expression in
RAW264.7 macrophages and appears to have altered the intracellular distribution of adenovirus, reducing the extranuclear aggregation. Our
results with chloroquine and the various inhibitors in these short-term
experiments cannot be explained on the basis of toxicity since >97%
of cells were viable under all conditions evaluated as determined by
trypan blue exclusion. Expression of adenoviral early genes such as
those of the E1 region has been postulated as important in stimulating
the inflammatory cascade during ARTI in the mouse model
(15). The adenovirus mutant used here was devoid of E1 genes
and also E3 region genes known to modulate inflammatory responses
(18) but still rapidly initiated inflammation during ARTI.
Thus, our data do not support a requirement for adenovirus early gene
expression in the initiation of pulmonary inflammation. Taken together,
our data suggest that the molecular event that initiates cytokine gene
expression in AM
during virus clearance occurs during or subsequent
to endosome acidification.
These observations have implications for the development of adenovirus
vectors for human gene therapy for cystic fibrosis and lung disorders.
Inflammation has been observed in multiple clinical trials where
replication-deficient adenovirus vectors have been administered to the
respiratory tract (7). Importantly, inflammation occurred
after vector administration to nasal and bronchial epithelium. Thus,
vector delivery to the alveolar surface cannot completely explain the
inflammatory host response as previously proposed (33).
Nasal inflammatory responses to adenovirus appear not to be explained
by an epithelial cell response because cultured primary airway
epithelial cells do not stimulate cytokines following in vitro
adenovirus infection (36). These prior findings may be
reconciled by the fact that macrophages are found on the epithelial surface distributed throughout the respiratory tract with a density in
proportion to the surface area (6, 10) and our observations that macrophages initiate the inflammatory response during adenovirus infection.
 |
ACKNOWLEDGMENTS |
We thank Keiko Takihara for the generous gift of the murine IL-6
cDNA, Kim Wilmer for help with animal husbandry, and Jeff Whitsett for
critical reading of the manuscript.
This work was supported by the Cystic Fibrosis Foundation (S887) and
the Children's Hospital Research Foundation, Cincinnati, Ohio.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Children's
Hospital Medical Center, Division of Pulmonary Biology, 3333 Burnet
Ave., Cincinnati, OH 45229. Phone: (513) 636-6361. Fax: (513) 636-3723. E-mail: Bruce.Trapnell{at}chmcc.org.
Present address: Department of Pediatrics, Harvard Medical School,
Boston, MA 02115.
Present address: Department of Laboratory Medicine, Yamagata
University School of Medicine, Yamagata 990-23, Japan.
 |
REFERENCES |
| 1.
|
Allen, R. D.,
T. A. Staley, and C. L. Sidman.
1993.
Differential cytokine expression in acute and chronic murine graft- versus-host-disease.
Eur. J. Immunol.
23:333-337[Medline].
|
| 2.
|
Andiman, W. A., and G. Miller.
1982.
Persistent infection with adenovirus types 5 and 6 in lymphoid cells from humans and woolly monkeys.
J. Infect. Dis.
145:83-88[Medline].
|
| 3.
|
Araki, N.,
M. T. Johnson, and J. A. Swanson.
1996.
A role for phosphoinositide 3-OH kinase in the completion of macropinocytosis and phagocytosis by macrophages.
J. Cell Biol.
135:1249-1260[Abstract/Free Full Text].
|
| 4.
|
Becroft, D. M.
1967.
Histopathology of fatal adenovirus infection of the respiratory tract in young children.
J. Clin. Pathol.
20:561-569[Abstract/Free Full Text].
|
| 5.
|
Bergelson, J. M.,
A. Krithivas,
L. Celi,
G. Droguett,
M. S. Horwitz,
T. Wickham,
R. L. Crowell, and R. W. Finberg.
1998.
The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses.
J. Virol.
72:415-419[Abstract/Free Full Text].
|
| 6.
|
Bezdicek, P., and R. G. Crystal.
1997.
Pulmonary macrophages, p. 859-875.
In
R. G. Crystal, P. J. Barnes, J. B. West, and E. R. Weibel (ed.), The lung: scientific foundations, 2nd ed., vol. 1. Lippincott-Raven, Philadelphia, Pa.
|
| 7.
|
Boucher, R. C.
1999.
Status of gene therapy for cystic fibrosis lung disease.
J. Clin. Investig.
103:441-445[Medline].
|
| 8.
|
Brody, S. L.,
M. Metzger,
C. Danel,
M. A. Rosenfeld, and R. G. Crystal.
1994.
Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.
Hum. Gene Ther.
5:821-836[Medline].
|
| 9.
|
Chu, Y.,
K. Sperber,
L. Mayer, and M. T. Hsu.
1992.
Persistent infection of human adenovirus type 5 in human monocyte cell lines.
Virology
188:793-800[CrossRef][Medline].
|
| 10.
|
Crapo, J. D.,
B. E. Barry,
P. Gehr,
M. Bachofen, and E. R. Weibel.
1982.
Cell number and cell characteristics of the normal human lung.
Am. Rev. Respir. Dis.
126:332-337[Medline].
|
| 11.
|
Crouch, E. C.
1998.
Collectins and pulmonary host defense.
Am. J. Respir. Cell Mol. Biol.
19:177-201[Abstract/Free Full Text].
|
| 12.
|
Crystal, R. G.,
N. G. McElvaney,
M. A. Rosenfeld,
C. S. Chu,
A. Mastrangeli,
J. G. Hay,
S. L. Brody,
H. A. Jaffe,
N. T. Eissa, and C. Danel.
1994.
Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis.
Nat. Genet.
8:42-51[CrossRef][Medline].
|
| 13.
|
Fraser, R. S.,
N. L. Muller,
N. Colman, and P. D. Pare.
1999.
Viral respiratory diseases, p. 994-996.
In
R. S. Fraser, and P. D. Pare's (ed.), Diagnosis of diseases of the chest, 4th ed., vol. 2. W. B. Saunders Co., Philadelphia, Pa.
|
| 14.
|
Ginsberg, H. S.,
L. L. Moldawer,
P. B. Sehgal,
M. Redington,
P. L. Kilian,
R. M. Chanock, and G. A. Prince.
1991.
A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia.
Proc. Natl. Acad. Sci. USA
88:1651-1655[Abstract/Free Full Text].
|
| 15.
|
Ginsberg, H. S., and G. A. Prince.
1994.
The molecular basis of adenovirus pathogenesis.
Infect. Agents Dis.
3:1-8[Medline].
|
| 16.
|
Greber, U. F.,
M. Suomalainen,
R. P. Stidwill,
K. Boucke,
M. W. Ebersold, and A. Helenius.
1997.
The role of the nuclear pore complex in adenovirus DNA entry.
EMBO J.
16:5998-6007[CrossRef][Medline].
|
| 17.
|
Greber, U. F.,
M. Willetts,
P. Webster, and A. Helenius.
1993.
Stepwise dismantling of adenovirus 2 during entry into cells.
Cell
75:477-486[CrossRef][Medline].
|
| 18.
|
Harrod, K. S.,
T. W. Hermiston,
B. C. Trapnell,
W. S. Wold, and J. A. Whitsett.
1998.
Lung-specific expression of adenovirus E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression.
Hum. Gene Ther.
9:1885-1898[Medline].
|
| 19.
|
Harrod, K. S.,
B. C. Trapnell,
K. Otake,
T. R. Korfhagen, and J. A. Whitsett.
1999.
SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection.
Am. J. Physiol.
277:L580-L588.
|
| 20.
|
Hidaka, C.,
E. Milano,
P. L. Leopold,
J. M. Bergelson,
N. R. Hackett,
R. W. Finberg,
T. J. Wickham,
I. Kovesdi,
P. Roelvink, and R. G. Crystal.
1999.
CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts.
J. Clin. Investig.
103:579-587[Medline].
|
| 21.
|
Horowitz, M. S.
1996.
Adenoviruses, p. 2149-2171.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven Publishers, New York, N.Y.
|
| 22.
|
Huang, S.,
R. I. Endo, and G. R. Nemerow.
1995.
Upregulation of integrins v 3 and v 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery.
J. Virol.
69:2257-2263[Abstract].
|
| 23.
|
Huang, S.,
T. Kamata,
Y. Takada,
Z. M. Ruggeri, and G. R. Nemerow.
1996.
Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells.
J. Virol.
70:4502-4508[Abstract].
|
| 24.
|
Jobe, A. H.,
T. Ueda,
J. A. Whitsett,
B. C. Trapnell, and M. Ikegami.
1996.
Surfactant enhances adenovirus-mediated gene expression in rabbit lungs.
Gene Ther.
3:775-779[Medline].
|
| 25.
|
Kaner, R. J.,
S. Worgall,
P. L. Leopold,
E. Stolze,
E. Milano,
C. Hidaka,
R. Ramalingam,
N. R. Hackett,
R. Singh,
J. Bergelson,
R. Finberg,
E. Falck-Pedersen, and R. G. Crystal.
1999.
Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.
Am. J. Respir. Cell Mol. Biol.
20:361-370[Abstract/Free Full Text].
|
| 26.
|
Knowles, M. R.,
K. W. Hohneker,
Z. Zhou,
J. C. Olsen,
T. L. Noah,
P. C. Hu,
M. W. Leigh,
J. F. Engelhardt,
L. J. Edwards,
K. R. Jones, et al.
1995.
A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis.
N. Engl. J. Med.
333:823-831[Abstract/Free Full Text].
|
| 27.
|
Lentsch, A. B.,
B. J. Czermak,
N. M. Bless,
N. Van Rooijen, and P. A. Ward.
1999.
Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB.
Am. J. Respir. Cell Mol. Biol.
20:692-698[Abstract/Free Full Text].
|
| 28.
|
Leopold, P. L.,
B. Ferris,
I. Grinberg,
S. Worgall,
N. R. Hackett, and R. G. Crystal.
1998.
Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells.
Hum. Gene Ther.
9:367-378[Medline].
|
| 29.
|
Li, E.,
D. Stupack,
G. M. Bokoch, and G. R. Nemerow.
1998.
Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases.
J. Virol.
72:8806-8812[Abstract/Free Full Text].
|
| 30.
|
Li, E.,
D. Stupack,
R. Klemke,
D. A. Cheresh, and G. R. Nemerow.
1998.
Adenovirus endocytosis via v integrins requires phosphoinositide-3-OH kinase.
J. Virol.
72:2055-2061[Abstract/Free Full Text].
|
| 31.
|
Marsh, M., and H. T. McMahon.
1999.
The structural era of endocytosis.
Science
285:215-220[Abstract/Free Full Text].
|
| 32.
|
McCoy, R. D.,
B. L. Davidson,
B. J. Roessler,
G. B. Huffnagle,
S. L. Janich,
T. J. Laing, and R. H. Simon.
1995.
Pulmonary inflammation induced by incomplete or inactivated adenoviral particles.
Hum. Gene Ther.
6:1553-1560[Medline].
|
| 33.
|
McElvaney, N. G., and R. G. Crystal.
1995.
IL-6 release and airway administration of human CFR cDNA adenovirus vector.
Nat. Med.
1:182-184[Medline].
|
| 34.
|
McKernan, L. N., and M. T. Largen.
1983.
Identification of multiple-molecular-weight forms of thymocyte comitogenic activity from the monocyte/macrophage cell line RAW 264.7.
Cell. Immunol.
80:84-96[CrossRef][Medline].
|
| 35.
|
Mittereder, N.,
K. L. March, and B. C. Trapnell.
1996.
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy.
J. Virol.
70:7498-7509[Abstract].
|
| 36.
|
Noah, T. L.,
I. A. Wortman,
P. C. Hu,
M. W. Leigh, and R. C. Boucher.
1996.
Cytokine production by cultured human bronchial epithelial cells infected with a replication-deficient adenoviral gene transfer vector or wild-type adenovirus type 5.
Am. J. Respir. Cell Mol. Biol.
14:417-424[Abstract].
|
| 37.
|
Otake, K.,
D. L. Ennist,
K. Harrod, and B. C. Trapnell.
1998.
Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses.
Hum. Gene Ther.
9:2207-2222[Medline].
|
| 38.
|
Perez, L., and L. Carrasco.
1994.
Involvement of the vacuolar H(+)-ATPase in animal virus entry.
J. Gen. Virol.
75:2595-606[Abstract/Free Full Text].
|
| 39.
|
Prince, G. A.,
D. D. Porter,
A. B. Jenson,
R. L. Horswood,
R. M. Chanock, and H. S. Ginsberg.
1993.
Pathogenesis of adenovirus type 5 pneumonia in cotton rats (Sigmodon hispidus).
J. Virol.
67:101-111[Abstract/Free Full Text].
|
| 40.
|
Rodriguez, E., and E. Everitt.
1996.
Adenovirus uncoating and nuclear establishment are not affected by weak base amines.
J. Virol.
70:3470-3477[Abstract].
|
| 41.
|
Rosenfeld, M. A.,
K. Yoshimura,
B. C. Trapnell,
K. Yoneyama,
E. R. Rosenthal,
W. Dalemans,
M. Fukayama,
J. Bargon,
L. E. Stier,
L. Stratford-Perricaudet, et al.
1992.
In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.
Cell
68:143-155[CrossRef][Medline].
|
| 42.
|
Rubin, B. A., and L. B. Rorke.
1988.
Adenovirus vaccines, p. 492-512.
In
S. A. Plotkin, and J. Y. Mortimer (ed.), Vaccines. W. B. Saunders, Philadelphia, Pa.
|
| 43.
|
Seglen, P. O.,
B. Grinde, and A. E. Solheim.
1979.
Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin.
Eur. J. Biochem.
95:215-225[Medline].
|
| 44.
|
Simon, R. H.,
J. F. Engelhardt,
Y. Yang,
M. Zepeda,
S. Weber-Pendleton,
M. Grossman, and J. M. Wilson.
1993.
Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study.
Hum. Gene Ther.
4:771-780[Medline].
|
| 45.
|
Suomalainen, M.,
M. Y. Nakano,
S. Keller,
K. Boucke,
R. P. Stidwill, and U. F. Greber.
1999.
Microtubule-dependent plus and minus end-directed motilities are competing processes for nuclear targeting of adenovirus.
J. Cell Biol.
144:657-672[Abstract/Free Full Text].
|
| 46.
|
Swanson, J. A.,
M. T. Johnson,
K. Beningo,
P. Post,
M. Mooseker, and N. Araki.
1999.
A contractile activity that closes phagosomes in macrophages.
J. Cell Sci.
112:307-316[Abstract].
|
| 47.
|
Trapnell, B. C.
1993.
Adenoviral vectors for gene transfer.
Adv. Drug Delivery Rev.
12:185-199[CrossRef].
|
| 48.
|
Trapnell, B. C.
1997.
Gene therapy for cystic fibrosis lung disease.
In
R. W. Wilmott (ed.), The pediatric lung. Birkhauser Verlag, Basel, Switzerland.
|
| 49.
|
Von Seggern, D. J.,
C. Y. Chiu,
S. K. Fleck,
P. L. Stewart, and G. R. Nemerow.
1999.
A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles.
J. Virol.
73:1601-1608[Abstract/Free Full Text].
|
| 50.
|
Wang, G.,
J. Zabner,
C. Deering,
J. Launspach,
J. Shao,
M. Bodner,
D. J. Jolly,
B. L. Davidson, and P. McCray.
2000.
Increasing epithelial junction permeability enhances gene transfer to airway epithelia In vivo.
Am. J. Respir. Cell Mol. Biol.
22:129-138[Abstract/Free Full Text].
|
| 51.
|
Wang, K.,
T. Guan,
D. A. Cheresh, and G. R. Nemerow.
2000.
Regulation of adenovirus membrane penetration by the cytoplasmic tail of integrin beta 5.
J. Virol.
74:2731-2739[Abstract/Free Full Text].
|
| 52.
|
Wang, K.,
S. Huang,
A. Kapoor-Munshi, and G. Nemerow.
1998.
Adenovirus internalization and infection require dynamin.
J. Virol.
72:3455-3458[Abstract/Free Full Text].
|
| 53.
|
Welsh, R. M., and G. C. Sen.
1997.
Nonspecific host responses to viral infections, p. 109-141.
In
N. Nathason (ed.), Viral pathogenesis. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 54.
|
Wickham, T. J.,
P. Mathias,
D. A. Cheresh, and G. R. Nemerow.
1993.
Integrins v 3 and v 5 promote adenovirus internalization but not virus attachment.
Cell
73:309-319[CrossRef][Medline].
|
| 55.
|
Wilmott, R. W.,
R. S. Amin,
C. R. Perez,
S. E. Wert,
G. Keller,
G. P. Boivin,
R. Hirsch,
J. De Inocencio,
P. Lu,
S. F. Reising,
S. Yei,
J. A. Whitsett, and B. C. Trapnell.
1996.
Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates.
Hum. Gene Ther.
7:301-318[Medline].
|
| 56.
|
Worgall, S.,
P. L. Leopold,
G. Wolff,
B. Ferris,
N. Van Roijen, and R. G. Crystal.
1997.
Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract.
Hum. Gene Ther.
8:1675-1684[Medline].
|
| 57.
|
Worgall, S.,
R. Singh,
P. L. Leopold,
R. J. Kaner,
N. R. Hackett,
N. Topf,
M. A. Moore, and R. G. Crystal.
1999.
Selective expansion of alveolar macrophages in vivo by adenovirus-mediated transfer of the murine granulocyte-macrophage colony-stimulating factor cDNA.
Blood
93:655-666[Abstract/Free Full Text].
|
| 58.
|
Yang, Y.,
Q. Li,
H. C. Ertl, and J. M. Wilson.
1995.
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses.
J. Virol.
69:2004-2015[Abstract].
|
| 59.
|
Yei, S.,
N. Mittereder,
K. Tang,
C. O'Sullivan, and B. C. Trapnell.
1994.
Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.
Gene Ther.
1:192-200[Medline].
|
| 60.
|
Yei, S.,
N. Mittereder,
S. Wert,
J. A. Whitsett,
R. W. Wilmott, and B. C. Trapnell.
1994.
In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.
Hum. Gene Ther.
5:731-744[Medline].
|
| 61.
|
Zabner, J.,
D. M. Petersen,
A. P. Puga,
S. M. Graham,
L. A. Couture,
L. D. Keyes,
M. J. Lukason,
J. A. St. George,
R. J. Gregory,
A. E. Smith, et al.
1994.
Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats.
Nat. Genet.
6:75-83[CrossRef][Medline].
|
| 62.
|
Zsengeller, Z. K.,
S. E. Wert,
C. J. Bachurski,
K. L. Kirwin,
B. C. Trapnell, and J. A. Whitsett.
1997.
Recombinant adenoviral vector disrupts surfactant homeostasis in mouse lung.
Hum. Gene Ther.
8:1331-1344[Medline].
|
| 63.
|
Zsengeller, Z. K.,
S. E. Wert,
W. M. Hull,
X. Hu,
S. Yei,
B. C. Trapnell, and J. A. Whitsett.
1995.
Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice.
Hum. Gene Ther.
6:457-467[Medline].
|
Journal of Virology, October 2000, p. 9655-9667, Vol. 74, No. 20
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zaiss, A. K., Vilaysane, A., Cotter, M. J., Clark, S. A., Meijndert, H. C., Colarusso, P., Yates, R. M., Petrilli, V., Tschopp, J., Muruve, D. A.
(2009). Antiviral Antibodies Target Adenovirus to Phagolysosomes and Amplify the Innate Immune Response. J. Immunol.
182: 7058-7068
[Abstract]
[Full Text]
-
Uchida, K., Nakata, K., Suzuki, T., Luisetti, M., Watanabe, M., Koch, D. E., Stevens, C. A., Beck, D. C., Denson, L. A., Carey, B. C., Keicho, N., Krischer, J. P., Yamada, Y., Trapnell, B. C.
(2009). Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood
113: 2547-2556
[Abstract]
[Full Text]
-
Xu, J., Xu, F., Barrett, E.
(2008). Metalloelastase in lungs and alveolar macrophages is modulated by extracellular substance P in mice. Am. J. Physiol. Lung Cell. Mol. Physiol.
295: L162-L170
[Abstract]
[Full Text]
-
Kaye, D. M., Preovolos, A., Marshall, T., Byrne, M., Hoshijima, M., Hajjar, R., Mariani, J. A., Pepe, S., Chien, K. R., Power, J. M.
(2007). Percutaneous Cardiac Recirculation-Mediated Gene Transfer of an Inhibitory Phospholamban Peptide Reverses Advanced Heart Failure in Large Animals. J Am Coll Cardiol
50: 253-260
[Abstract]
[Full Text]
-
Carey, B., Staudt, M. K., Bonaminio, D., van der Loo, J. C. M., Trapnell, B. C.
(2007). PU.1 Redirects Adenovirus to Lysosomes in Alveolar Macrophages, Uncoupling Internalization from Infection. J. Immunol.
178: 2440-2447
[Abstract]
[Full Text]
-
Kolb, M., Martin, G., Medina, M., Ask, K., Gauldie, J.
(2006). Gene therapy for pulmonary diseases.. Chest
130: 879-884
[Abstract]
[Full Text]
-
Kim, J., Ha, Y., Chae, C.
(2006). Potentiation of Porcine Circovirus 2-induced Postweaning Multisystemic Wasting Syndrome by Porcine Parvovirus Is Associated with Excessive Production of Tumor Necrosis Factor-{alpha}.. Vet Pathol
43: 718-725
[Abstract]
[Full Text]
-
Publicover, J., Ramsburg, E., Robek, M., Rose, J. K.
(2006). Rapid Pathogenesis Induced by a Vesicular Stomatitis Virus Matrix Protein Mutant: Viral Pathogenesis Is Linked to Induction of Tumor Necrosis Factor Alpha. J. Virol.
80: 7028-7036
[Abstract]
[Full Text]
-
Keriel, A., Rene, C., Galer, C., Zabner, J., Kremer, E. J.
(2006). Canine Adenovirus Vectors for Lung-Directed Gene Transfer: Efficacy, Immune Response, and Duration of Transgene Expression Using Helper-Dependent Vectors. J. Virol.
80: 1487-1496
[Abstract]
[Full Text]
-
Shayakhmetov, D. M., Li, Z.-Y., Ni, S., Lieber, A.
(2005). Interference with the IL-1-Signaling Pathway Improves the Toxicity Profile of Systemically Applied Adenovirus Vectors. J. Immunol.
174: 7310-7319
[Abstract]
[Full Text]
-
Stonebraker, J. R., Wagner, D., Lefensty, R. W., Burns, K., Gendler, S. J., Bergelson, J. M., Boucher, R. C., O'Neal, W. K., Pickles, R. J.
(2004). Glycocalyx Restricts Adenoviral Vector Access to Apical Receptors Expressed on Respiratory Epithelium In Vitro and In Vivo: Role for Tethered Mucins as Barriers to Lumenal Infection. J. Virol.
78: 13755-13768
[Abstract]
[Full Text]
-
Pickles, R. J.
(2004). Physical and Biological Barriers to Viral Vector-mediated Delivery of Genes to the Airway Epithelium. Proc Am Thorac Soc
1: 302-308
[Abstract]
[Full Text]
-
Meyerholz, D. K., Grubor, B., Gallup, J. M., Lehmkuhl, H. D., Anderson, R. D., Lazic, T., Ackermann, M. R.
(2004). Adenovirus-Mediated Gene Therapy Enhances Parainfluenza Virus 3 Infection in Neonatal Lambs. J. Clin. Microbiol.
42: 4780-4787
[Abstract]
[Full Text]
-
Albelda, S. M., Lau, K. C., Chien, P., Huang, Z.-Y., Arguiris, E., Bohen, A., Sun, J., Billet, J. A., Christofidou-Solomidou, M., Indik, Z. K., Schreiber, A. D.
(2004). Role for Platelet-Endothelial Cell Adhesion Molecule-1 in Macrophage Fc{gamma} Receptor Function. Am. J. Respir. Cell Mol. Bio.
31: 246-255
[Abstract]
[Full Text]
-
Cheng, Y.-H., Aronow, B. J., Hossain, S., Trapnell, B., Kong, S., Handwerger, S.
(2004). Critical role for transcription factor AP-2{alpha} in human trophoblast differentiation. Physiol. Genomics
18: 99-107
[Abstract]
[Full Text]
-
Chung, S.-W., Arnott, J. A., Yang, Y., Wong, P. M. C.
(2003). Presence of Prepackaged mRNA in Virions of DNA Adenovirus. J. Biol. Chem.
278: 50635-50640
[Abstract]
[Full Text]
-
de Perrot, M., Fischer, S., Liu, M., Imai, Y., Martins, S., Sakiyama, S., Tabata, T., Bai, X.-H., Waddell, T. K., Davidson, B. L., Keshavjee, S.
(2003). Impact of Human Interleukin-10 on Vector-Induced Inflammation and Early Graft Function in Rat Lung Transplantation. Am. J. Respir. Cell Mol. Bio.
28: 616-625
[Abstract]
[Full Text]
-
Lim, Y.-C., Garcia-Cardena, G., Allport, J. R., Zervoglos, M., Connolly, A. J., Gimbrone, M. A. Jr., Luscinskas, F. W.
(2003). Heterogeneity of Endothelial Cells from Different Organ Sites in T-Cell Subset Recruitment. Am. J. Pathol.
162: 1591-1601
[Abstract]
[Full Text]
-
Wiethe, C., Dittmar, K., Doan, T., Lindenmaier, W., Tindle, R.
(2003). Provision of 4-1BB Ligand Enhances Effector and Memory CTL Responses Generated by Immunization with Dendritic Cells Expressing a Human Tumor-Associated Antigen. J. Immunol.
170: 2912-2922
[Abstract]
[Full Text]
-
Berclaz, P.-Y., Zsengeller, Z., Shibata, Y., Otake, K., Strasbaugh, S., Whitsett, J. A., Trapnell, B. C.
(2002). Endocytic Internalization of Adenovirus, Nonspecific Phagocytosis, and Cytoskeletal Organization Are Coordinately Regulated in Alveolar Macrophages by GM-CSF and PU.1. J. Immunol.
169: 6332-6342
[Abstract]
[Full Text]
-
Berclaz, P.-Y., Shibata, Y., Whitsett, J. A., Trapnell, B. C.
(2002). GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma R-mediated phagocytosis and the IL-18/IFN-gamma -mediated molecular connection between innate and adaptive immunity in the lung. Blood
100: 4193-4200
[Abstract]
[Full Text]
-
Rice, J., Connor, R., Worgall, S., Moore, J. P., Leopold, P. L., Kaner, R. J., Crystal, R. G.
(2002). Inhibition of HIV-1 Replication in Alveolar Macrophages by Adenovirus Gene Transfer Vectors. Am. J. Respir. Cell Mol. Bio.
27: 214-219
[Abstract]
[Full Text]
-
Varnavski, A. N., Zhang, Y., Schnell, M., Tazelaar, J., Louboutin, J.-P., Yu, Q.-C., Bagg, A., Gao, G.-p., Wilson, J. M.
(2002). Preexisting Immunity to Adenovirus in Rhesus Monkeys Fails To Prevent Vector-Induced Toxicity. J. Virol.
76: 5711-5719
[Abstract]
[Full Text]
-
Zaiss, A.-K., Liu, Q., Bowen, G. P., Wong, N. C. W., Bartlett, J. S., Muruve, D. A.
(2002). Differential Activation of Innate Immune Responses by Adenovirus and Adeno-Associated Virus Vectors. J. Virol.
76: 4580-4590
[Abstract]
[Full Text]
-
Thomas, C. E., Edwards, P., Wickham, T. J., Castro, M. G., Lowenstein, P. R.
(2002). Adenovirus Binding to the Coxsackievirus and Adenovirus Receptor or Integrins Is Not Required To Elicit Brain Inflammation but Is Necessary To Transduce Specific Neural Cell Types. J. Virol.
76: 3452-3460
[Abstract]
[Full Text]
-
Mercier, S., Gahery-Segard, H., Monteil, M., Lengagne, R., Guillet, J.-G., Eloit, M., Denesvre, C.
(2002). Distinct Roles of Adenovirus Vector-Transduced Dendritic Cells, Myoblasts, and Endothelial Cells in Mediating an Immune Response against a Transgene Product. J. Virol.
76: 2899-2911
[Abstract]
[Full Text]
-
Shibata, Y., Zsengeller, Z., Otake, K., Palaniyar, N., Trapnell, B. C.
(2001). Alveolar macrophage deficiency in osteopetrotic mice deficient in macrophage colony-stimulating factor is spontaneously corrected with age and associated with matrix metalloproteinase expression and emphysema. Blood
98: 2845-2852
[Abstract]
[Full Text]
-
Zsengeller, Z. K., Ross, G. F., Trapnell, B. C., Szabo, C., Whitsett, J. A.
(2001). Adenovirus infection increases iNOS and peroxynitrite production in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol.
280: L503-L511
[Abstract]
[Full Text]
-
Towne, J. E., Krane, C. M., Bachurski, C. J., Menon, A. G.
(2001). Tumor Necrosis Factor-alpha Inhibits Aquaporin 5 Expression in Mouse Lung Epithelial Cells. J. Biol. Chem.
276: 18657-18664
[Abstract]
[Full Text]
-
Sunil, V. R., Connor, A. J., Guo, Y., Laskin, J. D., Laskin, D. L.
(2002). Activation of type II alveolar epithelial cells during acute endotoxemia. Am. J. Physiol. Lung Cell. Mol. Physiol.
282: L872-L880
[Abstract]
[Full Text]